Evidence map›Paper›PMID 32074014›Full record

ArticleJCO oncology practice2020

Performance Measures Based on How Adults With Cancer Feel and Function: Stakeholder Recommendations and Feasibility Testing in Six Cancer Centers.

Angela M Stover, Benjamin Y Urick, Allison M Deal, Randall Teal, Maihan B Vu, Jessica Carda-Auten, Jennifer Jansen, Arlene E Chung, Antonia V Bennett, Anne Chiang and 18 more

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in JCO oncology practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 1 country.

Angela M StoverDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Benjamin Y UrickDepartment of Pharmacy, Center for Medication Optimization in the Division of Practice Advancement and Clinical Education, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Allison M DealLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Randall TealLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Maihan B VuLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Jessica Carda-AutenLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Jennifer JansenLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Arlene E ChungLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Antonia V BennettDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Anne ChiangYale University and Smilow Cancer Center, Hartford, CT.
Charles CleelandUniversity of Texas MD Anderson Cancer Center, Houston, TX.
Yehuda DeutschMemorial Cancer Center, Hollywood, FL.
Edmund TaiPalo Alto Medical Foundation, Palo Alto, CA.
Dylan ZyllaPark Nicollet Oncology Research, Frauenshuh Cancer Center, HealthPartners Institute, Minneapolis, MN.
Loretta A WilliamsUniversity of Texas MD Anderson Cancer Center, Houston, TX.
Collette PitzenMN Community Measurement, Minneapolis, MN.
Claire SnyderJohns Hopkins University, Baltimore, MD.
Bryce ReeveDuke University, Durham, NC.
Tenbroeck SmithAmerican Cancer Society, Atlanta, GA.
Kristen McNiffKM Healthcare Consulting, Atlanta, GA.
David CellaNorthwestern University, Evanston, IL.
Michael N NeussVanderbilt University, Nashville, TN.
Robert MillerAmerican Society of Clinical Oncology, Alexandria, VA.
Thomas M AtkinsonMemorial Sloan Kettering Cancer Center, New York, NY.
Patricia A SpearsLineberger Comprehensive Cancer Center, Chapel Hill, NC.
Mary Lou SmithPatient Advocate.
Cindy GeogheganPatient Advocate.
Ethan M BaschDepartment of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC.
University of North Carolina at Chapel Hill · USUNC Lineberger Comprehensive Cancer CenterThe University of Texas MD Anderson Cancer Center · USAmerican Cancer Society · USAmerican Society of Clinical Oncology · USDuke University · USHartford Financial Services (United States)HealthPartners · USJohns Hopkins University · USMemorial Sloan Kettering Cancer Center · USNorthwestern University · USPalo Alto Institute · USPartners In Care · USPatient Advocate Foundation · USResearch Advocacy Network · USVanderbilt University · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
UNIV OF NORTH CAROLINA CLINICAL NUTRITION RESEARCH UNITP30DK056350 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUSAN M. SMITH · 1999 to 2026
$31.6M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)KL2TR001109 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$5.7M
Scripps Translational Science Institute (TL1)TL1TR000111 · NCATS · SCRIPPS RESEARCH INSTITUTE, THE · PI TOPOL, ERIC JEFFREY · 2012 to 2013
$219k
NCATS NIH HHS KL2 TR001109NCATS NIH HHS TL1 TR000111NCATS NIH HHS UL1 TR001863NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA016086NIDDK NIH HHS P30 DK056350
6 · The paper itself

Abstract

purposePatient-reported outcome measures (PROMs) that assess how patients feel and function have potential for evaluating quality of care. Stakeholder recommendations for PRO-based performance measures (PMs) were elicited, and feasibility testing was conducted at six cancer centers.

methodsInterviews were conducted with 124 stakeholders to determine priority symptoms and risk adjustment variables for PRO-PMs and perceived acceptability. Stakeholders included patients and advocates, caregivers, clinicians, administrators, and thought leaders. Feasibility testing was conducted in six cancer centers. Patients completed PROMs at home 5-15 days into a chemotherapy cycle. Feasibility was operationalized as ≥ 75% completed PROMs and ≥ 75% patient acceptability.

resultsStakeholder priority PRO-PMs for systemic therapy were GI symptoms (diarrhea, constipation, nausea, vomiting), depression/anxiety, pain, insomnia, fatigue, dyspnea, physical function, and neuropathy. Recommended risk adjusters included demographics, insurance type, cancer type, comorbidities, emetic risk, and difficulty paying bills. In feasibility testing, 653 patients enrolled (approximately 110 per site), and 607 (93%) completed PROMs, which indicated high feasibility for home collection. The majority of patients (470 of 607; 77%) completed PROMs without a reminder call, and 137 (23%) of 607 completed them after a reminder call. Most patients (72%) completed PROMs through web, 17% paper, or 2% interactive voice response (automated call that verbally asked patient questions). For acceptability, > 95% of patients found PROM items to be easy to understand and complete.

conclusionClinicians, patients, and other stakeholders agree that PMs that are based on how patients feel and function would be an important addition to quality measurement. This study also shows that PRO-PMs can be feasibly captured at home during systemic therapy and are acceptable to patients. PRO-PMs may add value to the portfolio of PMs as oncology transitions from fee-for-service payment models to performance-based care that emphasizes outcome measures.

Indexed as

Patient Reported Outcome MeasuresAdultFeasibility StudiesFemaleHumansMaleNeoplasmsStakeholder Participation

Identifiers

PMID32074014
PMCPMC7069703
OpenAlexW3008340798

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.